COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,620 Articles (22,913 medRxiv, 8,707 bioRxiv)

Most recent first Previous |  Page 39: Articles 381-390  | Next

SARS-CoV-2 membrane protein biogenesis
Ortiz Mateu, J., Pearson, G. J., Rius-Salvador, M., Sedighian, S., Pavlova, A., Alonso-Romero, J., Acosta-Caceres, J. M., Metola, A., Garcia-Murria, M. J., Skehel, J. M., Gumbart, J. C., Carlton, J. C., von Heijne, G., Sanchez-del Pino, M. M., Martinez-Gil, L., Mingarro, I.
10.64898/2026.01.19.700281 — Posted: 2026-01-20
Synthetic RNA-protein decoy granules to prevent SARS-CoV-2 infection
Willinger, O., Granik, N., Salomon, T., Goldberg, S., Amit, R.
10.64898/2026.01.16.699918 — Posted: 2026-01-19
Ultra-deep sequencing reveals intra-host diversity and co-infection-driven evolution of SARS-CoV-2
Moraga, C., Francisco Kirhman, F., Bernal, B., Poblete, S., Jullian, P., Gonzalez, A., Latorre, M., Di Genova, A.
10.64898/2026.01.15.699801 — Posted: 2026-01-19
Long-term healthcare resource use and cost associated with COVID-19 disease from a health system perspective. An equity-focused population-based cohort study
Ogunbameru, A., Swayze, S., Liu, K., Mishra, S., Sander, B.
10.64898/2026.01.16.26344255 — Posted: 2026-01-18
Non-binary gender identity associates with decreased functioning during an exceptional societal stress. A university community study during COVID-19 pandemic in Finland.
Salokangas, R. K. R., From, T., Hietala, J.
10.64898/2026.01.10.25343131 — Posted: 2026-01-18
Joint mechanistic modeling of viral and antibody responses to vaccines in non-human primates to quantify SARS-CoV-2 mechanistic correlates of protection
Alexandre, M., Marlin, R., Bossevot, L., Cavarelli, M., Dereuddre-Bosquet, N., Relouzat, F., Centlivre, M., Le Grand, R., Thiebaut, R., Levy, Y., Prague, M.
10.64898/2026.01.15.699647 — Posted: 2026-01-16
Outlier Detection in Single-Cell Transcriptomics Reveals Disease-Enriched Cytotoxic Immune Populations
Gupta, D., Gupta, A.
10.64898/2026.01.12.699092 — Posted: 2026-01-14
DIVAS: an R package for identifying shared and individual variations of multiomics data
Sun, Y., Marron, J. S., Le Cao, K.-A., Mao, J.
10.64898/2026.01.12.698985 — Posted: 2026-01-13
Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness and pathogenesis of SARS-CoV-2
Anderson-Daniels, J., Diefenbacher, M., Yount, B., Meganck, R. M., Tse, L. P. V., Burke, K. N., Miranda, H. A., Scobey, T. D., Lu, X., Stevens, L. J., Dinnon, K. H., Chapman, N. S., Pajon, C., Powers, J. M., Nguyen, C., Graham, R., Heaton, N. S., Baric, R. S., Denison, M. R., Sheahan, T. P.
10.64898/2026.01.12.698941 — Posted: 2026-01-13
Poly(A)-tail-length-dependent surveillance of viral RNA by PABPC1 orchestrates broad-spectrum antiviral defense
Yang, S., Zhou, L., Huang, X., Zhu, S., Yu, W., Guo, X., Liu, J., Deng, J., Zhang, Y., Liu, J., Liu, Q., Xiang, W., Guo, M., Wang, X., Zhang, Z., Huang, Z., Lan, K., Wang, H., Chen, Y.
10.64898/2026.01.12.699136 — Posted: 2026-01-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).